Antliabio110

N/A

Report date: 2023/06/16 15:13:28

NME

Base Information

Drug NameAntliabio110

Drug Alias NameAntliabio110Antliabio-110

ClassificationSmall molecules > Synthetic peptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsHypertension

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAntlia Bioscience Inc

China Registration ClassN/A

Develop Information

Active CompaniesAntlia Bioscience Inc

Inactive CompaniesN/A

Active IndicationsHypertension

Inactive IndicationsN/A

Other Information

ATC CodeN/A

Related LinksN/A